CREXONT
Total Payments
$1.2M
Transactions
2,587
Doctors
1,375
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.2M | 2,587 | 1,375 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $687,893 | 6 | 56.9% |
| Honoraria | $190,732 | 61 | 15.8% |
| Food and Beverage | $136,547 | 2,370 | 11.3% |
| Education | $122,963 | 31 | 10.2% |
| Travel and Lodging | $38,524 | 107 | 3.2% |
| Consulting Fee | $23,350 | 10 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,278 | 2 | 0.7% |
Payments by Type
Research
$687,893
6 transactions
General
$520,393
2,581 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Supratherapeutic Dose of Carbidopa in Healthy Subjects | Amneal Pharmaceuticals LLC | $359,897 | 1 |
| A Three-Way Crossover Thorough QT/QTc Study to Evaluate the Electrocardiographic Effects of a Supratherapeutic Dose of Carbidopa in Healthy Subjects | Amneal Pharmaceuticals LLC | $327,996 | 1 |
Top Doctors Receiving Payments for CREXONT — Page 14
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Neurology | Phoenix, AZ | $49.17 | 2 |
| , M.D | Neurology | Little Rock, AR | $48.78 | 2 |
| , MD | Neurology | Augusta, GA | $48.78 | 2 |
| , M.D | Neurology | Ann Arbor, MI | $48.78 | 2 |
| , MD | Neurology | East Brunswick, NJ | $48.64 | 2 |
| , FNP | Family | New Hartford, NY | $48.52 | 2 |
| , DO | Specialist | Sun City, AZ | $48.49 | 3 |
| , AG-ACNP | Acute Care | Sun City, AZ | $48.49 | 3 |
| , NP-C | Primary Care | Little Rock, AR | $48.33 | 3 |
| , MD | Internal Medicine | Poughkeepsie, NY | $48.21 | 4 |
| , MD | Neurology | Tyler, TX | $48.11 | 2 |
| , MD | Neurology | Leesburg, VA | $47.93 | 3 |
| , DO | Neurology | La Jolla, CA | $47.89 | 2 |
| , MD | Neurology | Kansas City, KS | $47.35 | 2 |
| , M.D | Neurology | Kansas City, KS | $47.35 | 2 |
| , MD, PHD | Neurology | Kansas City, KS | $47.35 | 2 |
| , M.D | Neurology | Kansas City, KS | $47.35 | 2 |
| , D.O | Neurology | Dallas, TX | $47.30 | 2 |
| , MBBS | Neurology | Rochester, MN | $47.30 | 2 |
| , FNP | Critical Care Medicine | Dallas, TX | $47.30 | 2 |
| , M.D | Neurology | Dallas, TX | $47.30 | 2 |
| Suzette Lynch | Family | Smithtown, NY | $47.15 | 2 |
| , DO | Clinical Neurophysiology | Glen Cove, NY | $47.15 | 2 |
| , MD | Neurology | Worcester, MA | $47.10 | 2 |
| , MD | Neurology | Cypress, TX | $46.60 | 2 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.2M
- Total Doctors 1,375
- Transactions 2,587
About CREXONT
CREXONT is a drug associated with $1.2M in payments to 1,375 healthcare providers, recorded across 2,587 transactions in the CMS Open Payments database. The primary manufacturer is Amneal Pharmaceuticals LLC.
Payment data is available from 2024 to 2024. In 2024, $1.2M was paid across 2,587 transactions to 1,375 doctors.
The most common payment nature for CREXONT is "Unspecified" ($687,893, 56.9% of total).
CREXONT is associated with 2 research studies, including "Supratherapeutic Dose of Carbidopa in Healthy Subjects" ($359,897).